Portuguese 
English 
Spanish 
5 min of reading 
0 comments 
With robust GDP and trade, investing in China via ETFs expands access to the Chinese market, but regulatory risk calls for disciplined allocation and method
China often appears in investment discussions surrounded by ready opinions, superficial cuts, and a lot of noise. However, when it comes to the portfolio, what matters is not the discourse, but the set of data, risks, and exposure paths. The proposal here is to look at China objectively, based on numbers and examples cited in the content, without “cheering” and without shortcuts.
One point that changes the tone of the debate is realizing that global investors and large managers have not ignored China, even with criticisms and tensions. The content mentions Warren Buffett’s case with BYD, as well as alternatives like ETFs and a direct warning about regulatory risk. The conclusion is not “buy China,” but rather: if considering China, do so with discipline and clear criteria.
Why China still divides opinions among investors
China carries contradictions that disturb any serious analysis: single party, censorship, state interventions, and a regulatory environment different from the Western one.
-
Coffee husk turns into cookies and even cosmetics in Brazil: research replaces 30% of flour, opens new sources of income, and helps producers gain value beyond the cup.
-
The European Union doubles tariffs on imported steel from 25 to 50 percent and nearly halves the volume of imports allowed to protect an industry that has already lost 100,000 jobs since 2008.
-
More than 47 million Brazilians have money sitting in banks without knowing it, and the total amount exceeds R$ 9 billion, but most have never checked the free system of the Central Bank that shows in seconds by CPF if you have something to receive and now allows automatic withdrawals via Pix without needing to talk to anyone.
-
Lula’s government signs a decree that reduces the workweek from 44 to 40 hours for 40,000 outsourced workers and indicates that the change may extend to other sectors in the future.
At the same time, the content reinforces that the investor needs to separate political preference from allocation decision, because the market prices risk and opportunity in a less emotional way.
The central point is simple: ignoring a country just because of narrative can turn into portfolio risk, especially when the country has significant economic and trade weight.
What made the view change: Buffett and BYD as a warning sign
In the content, the narrator reports that he spent years without investing in China and began to revise this stance when studying Warren Buffett’s investment in BYD.
The cited story is straightforward: Buffett reportedly invested $230 million in BYD in 2008, maintained the position for 17 years, and exited in 2025 with a gain of over 30 times.
More important than the number itself is the message: if an investor of that caliber accepted the China risk in a Chinese company, it is worth understanding why. This does not turn China into a “must-have,” but it dismantles the idea that “no serious person touches this.”
China in numbers: economic size and market weight
The content cites China as the second-largest economy in the world, with a GDP of $20.44 trillion. It also points to a growth of 5% in 2025 and a target between 4.5% and 5% for 2026, reinforcing the reading that it is not a stagnant country, but rather an economic bloc still in motion.
In the market segment, the combined capitalization of exchanges like Shanghai and Shenzhen appears at US$ 15.4 trillion, making it the second largest market on the planet.
And in foreign trade, the cited figure is US$ 6.3 trillion, with China described as the largest trading nation of goods.
The practical summary is: size, liquidity, and global relevance exist, and this changes the responsibility of analysis.
China and Brazil: a trading partner and a bond that already exists
The content highlights that the United States would be China’s largest trading partner, with US$ 560 billion traded in 2025, despite political rhetoric.
It also brings up the Brazil and China relationship, citing trade of US$ 171 billion and noting that it would be more than double the trade with the United States.
This part serves as an important reminder: even those who do not “invest in China” already coexist with China in the real economy, through exports, imports, production chains, and entire sectors influenced by prices and demand.
China as a powerhouse in technology and scientific base
The content states that China is no longer seen merely as a manufacturing hub and has begun to be presented as a leading country in AI, electric vehicles, solar energy, semiconductors, and advanced manufacturing.
It also mentions companies like Tencent and Alibaba among major global names and highlights a scenario of accelerated technological competition.
Furthermore, the idea emerges that China has the largest number of PhDs in the world and attracts talent, a point used to support the thesis that research capacity and human capital matter in the pace of innovation.
Here, caution is essential: strong technology does not eliminate investment risk, but changes the scale of “why to look.”
How to gain exposure to China: ETFs, BDRs, and direct access
The content describes different routes to invest in China, with a preference for broad and diversified solutions rather than choosing company by company.
The most direct criticism is about ETFs listed in Brazil that invest in another ETF abroad, which could generate a “double toll” of costs. Still, the text mentions that there is a popular ETF, China 11, which replicates an index with hundreds of companies.
Next, the content points out an alternative considered more efficient for offering more direct exposure to the Chinese stock market via the Brazilian market: PKIN 11, cited as an ETF that invests in the China Universal SCI300, composed of the 300 largest and most liquid companies, with significant presence in sectors such as finance, technology, consumer, health, and materials.
TECX11 also appears as an option focused on technology companies. And, outside Brazil, ETFs traded in the United States are mentioned as access methods, in addition to BDRs of Chinese companies, with the caveat that they may involve indirect structures.
The logic defended is: to begin with, diversification and simplicity tend to be more important than trying to “pick the stock”.
Risks of investing in China: regulation, governance, geopolitics, and currency
Here is the most important point to stay grounded. The content states that regulatory risk in China is real, citing a regulatory wave in 2021 that reportedly knocked down companies like Alibaba and Tencent by over 50% and also changes that affected educational sectors, with companies “disappearing” after rule changes.
Additionally, the topic of transparency and different accounting standards comes into play, with less visibility of corporate governance and more limited access to information in smaller companies.
On top of that, there is the geopolitical dimension, with tensions between China and the United States, tariffs, technological restrictions, and the dispute over Taiwan cited as risk factors.
Finally, the content emphasizes the currency complexity, with the Chinese currency not being fully convertible, which adds layers to the investment. The summary is clear: it is not a “theoretical” risk, and therefore the choice of vehicle and the discipline of allocation matter.
Disciplined allocation: criteria and size before product
The content suggests starting small and evolving with study. The idea mentioned is that a 3% exposure to China would already be better than zero for those who have nothing, as long as it makes sense in the portfolio and the investor understands what they are buying.
More important than “which ETF” is the correct mental order:
understand China in numbers, choose a simple vehicle, limit initial exposure, and accept that regulatory risk is part of the package.
Do you already have China in your portfolio or do you still prefer to stay out because of regulatory risk?
Seja o primeiro a reagir!